Kreis Leslie W. Insider Trading Activity

Average Profitability
5.55%
Insider Buys Quantity
5
Insider Buys Sum
$2.18M
Insider Sells Quantity
8
Insider Sells Sum
$3.15M

Insider Activity of Kreis Leslie W.

Biography of Kreis Leslie W.

No biography is available at this moment.

2025-06-27PurchaseActuate Therapeutics Inc
ACTU
71,428
0.3203%
$7.00$499,996+0.92%
2025-06-13SaleLantern Pharma Inc.
LTRN
10 percent owner
40,000
0.3758%
$3.09$123,600+12.13%
2025-06-12SaleLantern Pharma Inc.
LTRN
10 percent owner
60,647
0.5885%
$3.38$204,987+5.88%
2025-06-11SaleLantern Pharma Inc.
LTRN
10 percent owner
950
0.0089%
$3.40$3,230+0.89%
2025-06-10SaleLantern Pharma Inc.
LTRN
10 percent owner
16
0.0001%
$3.40$54+1.19%
2025-05-29SaleLantern Pharma Inc.
LTRN
10 percent owner
20,200
0.1813%
$3.03$61,206+7.99%
2025-05-28SaleLantern Pharma Inc.
LTRN
10 percent owner
15,000
0.1391%
$2.87$43,050+17.42%
2025-05-27SaleLantern Pharma Inc.
LTRN
10 percent owner
21,037
0.2052%
$3.05$64,163+16.21%
2024-05-24SaleLantern Pharma Inc.
LTRN
10 percent owner
20,000
0.1889%
$6.33$126,600-39.08%
2024-05-23SaleLantern Pharma Inc.
LTRN
10 percent owner
10,000
0.0932%
$6.25$62,500-38.6%
2024-02-29SaleLantern Pharma Inc.
LTRN
10 percent owner
19,703
0.1653%
$4.87$95,954-11.64%
2024-02-28SaleLantern Pharma Inc.
LTRN
10 percent owner
74,297
0.6556%
$4.85$360,340-16.27%
2024-02-27SaleLantern Pharma Inc.
LTRN
10 percent owner
50,000
0.4668%
$4.40$220,000-4.89%
2024-01-17SaleLantern Pharma Inc.
LTRN
10 percent owner
58,889
0.6101%
$4.20$247,334+11.26%
2023-11-29SaleLantern Pharma Inc.
LTRN
10 percent owner
145,348
1.1501%
$3.44$499,997+7.42%
2022-12-12PurchaseIN8bio, Inc.
INAB
director
75,001
0.359%
$2.48$185,912-45.34%
2022-11-28PurchaseCognition Therapeutics, Inc.
CGTX
director
16,064
0.0706%
$2.65$42,565-31.76%
2022-11-16PurchaseCognition Therapeutics, Inc.
CGTX
director
71,000
0.3069%
$1.40$99,400+27.74%
2022-11-15PurchaseCognition Therapeutics, Inc.
CGTX
director
1.5M
5.2511%
$1.20$1.8M+20.69%
2022-11-08SaleLantern Pharma Inc.
LTRN
director
350,000
3.233%
$4.40$1.54M+13.9%
Total: 21
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.